EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thiazol-4-yl-Methylthio-Quinazolin-4(3H)-ones as Anticonvulsant Compounds: Chemical Design, Computational Studies, and Biological Evaluation

Daniel Ungureanu iD, Anamaria Apan iD, Cristina Mogoșan iD, Radu Tamaian iD, Brîndușa Tiperciuc iD, Gabriel Marc iD, Raluca Pele iD, Laurian Vlase iD, Adrian Pîrnău iD, Cristina Moldovan iD, Ioana Ionuț, Anca Stana iD und 1 weitere

International Journal of Molecular Sciences · 08.07.2026 · 27 (14) · 6107

DOI: 10.3390/ijms27146107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.07.2026. Verfasst von Daniel Ungureanu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cl…. Hauptthemen laut MEDLINE: Anticonvulsants, Seizures, Drug Design, Quinazolinones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iuliu Hațieganu University of Medicine and Pharmacy, Ministry of Education, Ministry of Investments and European Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The purpose of this study was the chemical design, synthesis, and evaluation of the anticonvulsant potential of 15 novel thiazolyl-methylthio-quinazolin-4(3H)-one hybrid compounds (4a-o). The compounds were designed based on a scaffold that reunited thiazole and quinazolin-4(3H)-one heterocycles of two well-known anticonvulsants, clomethiazole and methaqualone, through a condensation reaction. The compounds were evaluated in vivo for anticonvulsant activity using the pentylenetetrazole-induced seizure animal model. A Rotarod test was employed to evaluate the neuromotor coordination after the administration of the tested compounds, and a flumazenil antagonism assay was subsequently performed to investigate if the observed anticonvulsant effects were mediated through the compounds’ interaction with the GABAA receptor. The in silico assessment consisted of molecular docking, evaluation of the druggability, and ADMETox prediction. All compounds presented anticonvulsant activity to varying degrees. The most notable activity was observed in compounds 4k (ED50 = 84.313 mg/kg) and 4c (ED50 = 178.165 mg/kg). The in vivo results positively correlated with the observations drawn in the molecular docking study on the human α1β2γ2 GABAA receptor and on the NR1 ligand-binding core of the NMDA receptor. The potential of anticonvulsant activity was also supported by the druggability and ADMETox predictions that highlighted an increased possibility of brain–blood barrier permeation, supported by the computed parameters TPSA, logD, and logBB. The results of the flumazenil antagonism assay additionally highlighted the possible mechanism of action of compounds 4c and 4k as positive allosteric modulators of the GABAA receptor. Preliminary evaluation confirmed the anticonvulsant potential of the tested compounds, with further testing being necessary for a better understanding and confirmation of the activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsSeizuresDrug DesignQuinazolinonesQuinazolinesThiazolesAnimalsMolecular Docking SimulationReceptors, GABA-AMiceMalePentylenetetrazoleStructure-Activity Relationship

Stichwörter der Autor:innen

anticonvulsanthybrid compoundsquinazolin-4(3H)-onethiazole

Substanzen

AnticonvulsantsReceptors, GABA-AQuinazolinonesPentylenetetrazoleQuinazolinesThiazoles

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
  • Department of Pharmacology, Physiology, Pathophysiology, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 6A Louis Pasteur Street, 400349 Cluj-Napoca, Romania.
  • ICSI Business, National Institute for Research and Development for Cryogenic and Isotopic Technologies-ICSI Rm. Vâlcea, 4 Uzinei Street, 240050 Râmnicu Vâlcea, Romania.
  • Department of Organic Chemistry, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
  • Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
  • National Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donath Street, 400293 Cluj-Napoca, Romania.

ORCID-Profile: Daniel Ungureanu, Anamaria Apan, Cristina Mogoșan, Radu Tamaian, Brîndușa Tiperciuc, Gabriel Marc, Raluca Pele, Laurian Vlase, Adrian Pîrnău, Cristina Moldovan, Anca Stana

Förderung

  • Iuliu Hațieganu University of Medicine and Pharmacy
  • Ministry of Education
  • Ministry of Investments and European Projects

Zitieren

APA

Ungureanu, D., Apan, A., Mogoșan, C., Tamaian, R., Tiperciuc, B., Marc, G., Pele, R., Vlase, L., Pîrnău, A., Moldovan, C., Ionuț, I., Stana, A., & Oniga, O. (2026). Thiazol-4-yl-Methylthio-Quinazolin-4(3H)-ones as Anticonvulsant Compounds: Chemical Design, Computational Studies, and Biological Evaluation. International Journal of Molecular Sciences, 27(14), 6107. https://doi.org/10.3390/ijms27146107

Vancouver

Ungureanu D, Apan A, Mogoșan C, Tamaian R, Tiperciuc B, Marc G, et al. Thiazol-4-yl-Methylthio-Quinazolin-4(3H)-ones as Anticonvulsant Compounds: Chemical Design, Computational Studies, and Biological Evaluation. International Journal of Molecular Sciences. 2026;27(14):6107. doi:10.3390/ijms27146107

BibTeX
@article{Ungureanu2026,
  author = {Ungureanu, Daniel and Apan, Anamaria and Mogoșan, Cristina and Tamaian, Radu and Tiperciuc, Brîndușa and Marc, Gabriel and Pele, Raluca and Vlase, Laurian and Pîrnău, Adrian and Moldovan, Cristina and Ionuț, Ioana and Stana, Anca and Oniga, Ovidiu},
  title = {Thiazol-4-yl-Methylthio-Quinazolin-4(3H)-ones as Anticonvulsant Compounds: Chemical Design, Computational Studies, and Biological Evaluation},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {14},
  pages = {6107},
  doi = {10.3390/ijms27146107}
}
Kostenlos starten →